Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003701362 | SCV004457313 | pathogenic | not provided | 2023-04-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser669Valfs*40) in the ABCC8 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCC8 are known to be pathogenic (PMID: 20685672, 23345197). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ABCC8-related conditions. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005047770 | SCV005676378 | likely pathogenic | Diabetes mellitus, transient neonatal, 2; Hyperinsulinemic hypoglycemia, familial, 1; Leucine-induced hypoglycemia; Type 2 diabetes mellitus; Diabetes mellitus, permanent neonatal 3 | 2024-04-24 | criteria provided, single submitter | clinical testing |